Annual EBIT
-$41.46 M
-$9.89 M-31.31%
December 31, 2023
Summary
- As of February 8, 2025, LVTX annual earnings before interest & taxes is -$41.46 million, with the most recent change of -$9.89 million (-31.31%) on December 31, 2023.
- During the last 3 years, LVTX annual EBIT has fallen by -$25.92 million (-166.78%).
- LVTX annual EBIT is now -331.86% below its all-time high of -$9.60 million, reached on December 31, 2019.
Performance
LVTX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$11.29 M
-$1.92 M-20.55%
September 30, 2024
Summary
- As of February 8, 2025, LVTX quarterly earnings before interest & taxes is -$11.29 million, with the most recent change of -$1.92 million (-20.55%) on September 30, 2024.
- Over the past year, LVTX quarterly EBIT has dropped by -$558.00 thousand (-5.20%).
- LVTX quarterly EBIT is now -618.33% below its all-time high of -$1.57 million, reached on September 30, 2022.
Performance
LVTX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$26.25 M
-$558.00 K-2.17%
September 30, 2024
Summary
- As of February 8, 2025, LVTX TTM earnings before interest & taxes is -$26.25 million, with the most recent change of -$558.00 thousand (-2.17%) on September 30, 2024.
- Over the past year, LVTX TTM EBIT has increased by +$19.78 million (+42.97%).
- LVTX TTM EBIT is now -556.74% below its all-time high of -$4.00 million, reached on March 31, 2020.
Performance
LVTX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
LVTX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -31.3% | -5.2% | +43.0% |
| 3 y3 years | -166.8% | -5.2% | +43.0% |
| 5 y5 years | -331.9% | -5.2% | +43.0% |
LVTX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -31.3% | +0.3% | -618.3% | +16.7% | -2.2% | +43.0% |
| 5 y | 5-year | -331.9% | +0.3% | -618.3% | +42.4% | -556.7% | +43.0% |
| alltime | all time | -331.9% | +0.3% | -618.3% | +42.4% | -556.7% | +43.0% |
LAVA Therapeutics NV EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$11.29 M(+20.6%) | -$26.25 M(+2.2%) |
| Jun 2024 | - | -$9.36 M(+379.6%) | -$25.69 M(-14.0%) |
| Mar 2024 | - | -$1.95 M(-46.5%) | -$29.88 M(-27.9%) |
| Dec 2023 | -$41.46 M(+31.3%) | -$3.65 M(-66.0%) | -$41.46 M(-9.9%) |
| Sep 2023 | - | -$10.73 M(-20.8%) | -$46.03 M(+24.8%) |
| Jun 2023 | - | -$13.54 M(+0.0%) | -$36.87 M(+7.2%) |
| Mar 2023 | - | -$13.54 M(+64.8%) | -$34.40 M(+9.0%) |
| Dec 2022 | -$31.58 M | -$8.22 M(+423.0%) | -$31.58 M(+3.0%) |
| Sep 2022 | - | -$1.57 M(-85.8%) | -$30.66 M(-18.1%) |
| Jun 2022 | - | -$11.08 M(+3.4%) | -$37.45 M(+9.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$10.71 M(+46.8%) | -$34.19 M(-20.6%) |
| Dec 2021 | -$41.57 M(+167.5%) | -$7.30 M(-12.8%) | -$43.07 M(+9.8%) |
| Sep 2021 | - | -$8.37 M(+7.0%) | -$39.22 M(+13.1%) |
| Jun 2021 | - | -$7.82 M(-60.1%) | -$34.68 M(+13.0%) |
| Mar 2021 | - | -$19.59 M(+469.3%) | -$30.71 M(+103.2%) |
| Dec 2020 | -$15.54 M(+61.9%) | -$3.44 M(-10.3%) | -$15.12 M(+29.5%) |
| Sep 2020 | - | -$3.84 M(-0.1%) | -$11.67 M(+49.0%) |
| Jun 2020 | - | -$3.84 M(-3.9%) | -$7.84 M(+96.1%) |
| Mar 2020 | - | -$4.00 M | -$4.00 M |
| Dec 2019 | -$9.60 M | - | - |
FAQ
- What is LAVA Therapeutics NV annual earnings before interest & taxes?
- What is the all time high annual EBIT for LAVA Therapeutics NV?
- What is LAVA Therapeutics NV annual EBIT year-on-year change?
- What is LAVA Therapeutics NV quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for LAVA Therapeutics NV?
- What is LAVA Therapeutics NV quarterly EBIT year-on-year change?
- What is LAVA Therapeutics NV TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for LAVA Therapeutics NV?
- What is LAVA Therapeutics NV TTM EBIT year-on-year change?
What is LAVA Therapeutics NV annual earnings before interest & taxes?
The current annual EBIT of LVTX is -$41.46 M
What is the all time high annual EBIT for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high annual earnings before interest & taxes is -$9.60 M
What is LAVA Therapeutics NV annual EBIT year-on-year change?
Over the past year, LVTX annual earnings before interest & taxes has changed by -$9.89 M (-31.31%)
What is LAVA Therapeutics NV quarterly earnings before interest & taxes?
The current quarterly EBIT of LVTX is -$11.29 M
What is the all time high quarterly EBIT for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high quarterly earnings before interest & taxes is -$1.57 M
What is LAVA Therapeutics NV quarterly EBIT year-on-year change?
Over the past year, LVTX quarterly earnings before interest & taxes has changed by -$558.00 K (-5.20%)
What is LAVA Therapeutics NV TTM earnings before interest & taxes?
The current TTM EBIT of LVTX is -$26.25 M
What is the all time high TTM EBIT for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high TTM earnings before interest & taxes is -$4.00 M
What is LAVA Therapeutics NV TTM EBIT year-on-year change?
Over the past year, LVTX TTM earnings before interest & taxes has changed by +$19.78 M (+42.97%)